SCHEMBL7254407

SCHEMBL7254407

Cc1ncoc1OC(=O)O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.37
RAB9A P51151 5/20 0.37
KMT2A Q03164 4/20 0.35
MAPT P10636 3/20 0.35
ALDH1A1 P00352 10/20 0.35
LMNA P02545 5/20 0.35
HSD17B10 Q99714 5/20 0.35
TSHR P16473 2/20 0.35
SMN1; SMN2 Q16637 4/20 0.34
MAPK1 P28482 1/20 0.34
PKM P14618 4/20 0.33
CHRNA4 P43681 2/20 0.33
CHRNB2 P17787 1/20 0.33
CHRNB4 P30926 1/20 0.33
CHRNA3 P32297 1/20 0.33
CHRNA7 P36544 1/20 0.33
POLB P06746 2/20 0.32
ESR1 P03372 1/20 0.32
ESR2 Q92731 1/20 0.32
GLA P06280 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL618431 0.68
SCHEMBL8616571 0.66 KMT2A (0.50) NPC1RAB9AKMT2AMAPTALDH1A1
SCHEMBL6152260 0.65 ALDH1A1 (0.33) NPC1RAB9AMAPTALDH1A1LMNA
SCHEMBL19183362 0.64
SCHEMBL23413226 0.64 GSK3B (0.36) NPC1RAB9AKMT2AMAPTALDH1A1
SCHEMBL14351455 0.64 LMNA (0.50) NPC1RAB9AKMT2AMAPTALDH1A1
SCHEMBL4613286 0.64 ALDH1A1 (0.33) NPC1RAB9AMAPTALDH1A1LMNA
SCHEMBL4612505 0.64 ALDH1A1 (0.41) NPC1RAB9AKMT2AMAPTALDH1A1
SCHEMBL12230949 0.64
SCHEMBL185620 0.64 LMNA (0.35) KMT2AMAPTALDH1A1LMNAHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2721015-B1 PROCESS FOR 4-METHYLOXAZOLE-5-CARBOXAMIDE DSM IP ASSETS BV (NL) 2017-03-01 EP claimed
WO-2003053959-A1 HETEROCYCLYLAMINO CARBONYLURACILS BAYER HEALTHCARE AG (DE) 2003-07-03 WO disclosed
EP-0037471-A1 1-Aroyl-2-phenylamino-2-imidazolines, their preparation and their pharmaceutical compositions BASF Aktiengesellschaft (DE) 1981-10-14 EP disclosed